An Act relating to patient choice in dispensing of clinician-administered drugs
H 4956 requires health insurance plans to cover clinician-administered drugs (outpatient prescriptions typically given in clinics or hospitals, like IV therapies) without extra costs or restrictions. It prohibits insurers from charging patients higher copays, denying coverage, or forcing them to use specific pharmacies when getting these drugs from their chosen provider or pharmacy. The bill also bans insurers from limiting coverage based on where the drug is dispensed or reducing payments to providers who source drugs from non-network pharmacies. This directly affects patients seeking these treatments, healthcare providers, and health benefit carriers. Insurers may offer but cannot mandate home infusion services or external infusion sites.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 28, 2026
Last action Jul 9, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
2
Committee
2
Jan 28, 2026
Lower · Passed
Reported favorably by committee and referred to the committee on Health Care Financing
lower
Jan 28, 2026
Lower · Passed
Reported from the committee on Financial Services
lower
0 primary · 1 co-sponsor
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about H 4956
Scope: MA
Hi! I can help you understand H 4956. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline